Population-level variation in enhancer expression identifies disease mechanisms in the human brain
暂无分享,去创建一个
Kelsey S. Montgomery | L. Klei | J. Buxbaum | B. Devlin | K. Brennand | R. Gur | V. Haroutunian | A. Chess | S. Berretta | D. Ruderfer | S. Marenco | Yungil Kim | P. Auluck | S. Akbarian | Wen Zhang | R. Visintainer | E. Domenici | Samir Rahman | P. Roussos | J. Fullard | J. Bendl | B. Lipska | C. Hahn | G. Hoffman | B. Zeng | Jiebiao Wang | Bibi S. Kassim | M. Filosi | K. Girdhar | M. Iskhakova | Michael B. Fernando | Pengfei Dong | K. Townsley | G. Voloudakis | L. Sloofman | Pasha Apontes | J. Vicari | Ruth Misir | S. Kleopoulos | Laura G. Sloofman | Lizette Couto | Olivia Devillers | A. Gulyás-Kovács | Eva Xia | A. Mandal | D. Lewis | S. Jiang | S. Sieberts | Michael Breen | Mette A. Peters | R. Gur | Andrew Attila Bibi Eva Joseph D. Laura Lizette Mariana Ma Chess Gulyás-Kovács Kassim Xia Buxbaum Slo | Mariana Amaro | Yixian Ma | Francis T. McMahon | Lide Han | M. Peters | Shan Jiang | Francis McMahon | Ajeet Mandal | Marina Iskhakova | Kiran Girdhar | S. Kleopoulos
[1] Michael F. Green,et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia , 2022, Nature.
[2] Haiyuan Yu,et al. A comparison of experimental assays and analytical methods for genome-wide identification of active enhancers , 2022, Nature Biotechnology.
[3] P. Roussos,et al. Multi-ancestry eQTL meta-analysis of human brain identifies candidate causal variants for brain-related traits , 2022, Nature Genetics.
[4] Dan J Stein,et al. Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology , 2021, Nature Genetics.
[5] Y. Hurd,et al. Common schizophrenia risk variants are enriched in open chromatin regions of human glutamatergic neurons , 2020, Nature Communications.
[6] Han Liang,et al. A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer. , 2020, Cancer cell.
[7] Y. Gilad,et al. Where Are the Disease-Associated eQTLs? , 2020, Trends in genetics : TIG.
[8] W. Kraus,et al. Spirits in the Material World: Enhancer RNAs in Transcriptional Regulation. , 2020, Trends in biochemical sciences.
[9] P. Roussos,et al. dream: Powerful differential expression analysis for repeated measures designs. , 2020, Bioinformatics.
[10] V. Sartorelli,et al. Enhancer RNAs are an important regulatory layer of the epigenome , 2020, Nature Structural & Molecular Biology.
[11] David B. Goldstein,et al. Enhancer Domains Predict Gene Pathogenicity and Inform Gene Discovery in Complex Disease. , 2020, American journal of human genetics.
[12] Sonja W. Scholz,et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.
[13] Shayne D. Wierbowski,et al. Transcription imparts architecture, function, and logic to enhancer units , 2019, Nature Genetics.
[14] S. Goldman,et al. Glial cells in schizophrenia: a unified hypothesis. , 2019, The lancet. Psychiatry.
[15] Christopher D. Brown,et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.
[16] Simon C. Potter,et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.
[17] Kelsey S. Montgomery,et al. CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder , 2019, Scientific Data.
[18] K. Brennand,et al. Synergistic effects of common schizophrenia risk variants , 2019, Nature Genetics.
[19] Alkes L. Price,et al. Quantifying genetic effects on disease mediated by assayed gene expression levels , 2019, Nature Genetics.
[20] P. Fraser,et al. Long-range enhancer–promoter contacts in gene expression control , 2019, Nature Reviews Genetics.
[21] Hagen U. Tilgner,et al. SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse , 2019, Neuron.
[22] A. Kundaje,et al. The ENCODE Blacklist: Identification of Problematic Regions of the Genome , 2019, Scientific Reports.
[23] M. Owen,et al. Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk , 2019, Nature Genetics.
[24] David A. Knowles,et al. Opportunities and challenges for transcriptome-wide association studies , 2019, Nature Genetics.
[25] J. Sutcliffe,et al. A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data , 2019, Nature Neuroscience.
[26] D. Geschwind,et al. Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders , 2019, Cell.
[27] John P. Rice,et al. Identification of common genetic risk variants for autism spectrum disorder , 2019, Nature Genetics.
[28] V. Vacic,et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways , 2019, Nature Genetics.
[29] Marc S. Halfon,et al. Studying Transcriptional Enhancers: The Founder Fallacy, Validation Creep, and Other Biases. , 2019, Trends in genetics : TIG.
[30] E. Schadt,et al. Integrative transcriptome imputation reveals tissue-specific and shared biological mechanisms mediating susceptibility to complex traits , 2019, Nature Communications.
[31] Jonathan P. Beauchamp,et al. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences , 2019, Nature Genetics.
[32] Timothy J. Hohman,et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.
[33] Annie W Shieh,et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder , 2018, Science.
[34] Prashant S. Emani,et al. Comprehensive functional genomic resource and integrative model for the human brain , 2018, Science.
[35] David Haussler,et al. The UCSC Genome Browser database: 2019 update , 2018, Nucleic Acids Res..
[36] Anthony J. Payne,et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.
[37] Alicia R. Martin,et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.
[38] Michael E. Greenberg,et al. Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior , 2018, Neuron.
[39] Benjamin A. Logsdon,et al. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease , 2018, Scientific Data.
[40] Annie W Shieh,et al. Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia , 2018, Nature Communications.
[41] M. Maccarrone,et al. 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. , 2018, Progress in lipid research.
[42] Y. Hurd,et al. An atlas of chromatin accessibility in the adult human brain , 2018, Genome research.
[43] Z. Weng,et al. Cell-specific histone modification maps link schizophrenia risk to the neuronal epigenome , 2018, Nature Neuroscience.
[44] J. Weinstein,et al. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. , 2018, Cell.
[45] Timothy A. Miller,et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic , 2018 .
[46] D. Posthuma,et al. Item-level analyses reveal genetic heterogeneity in neuroticism , 2018, Nature Communications.
[47] T. Meyer,et al. Transcription-coupled changes in nuclear mobility of mammalian cis-regulatory elements , 2018, Science.
[48] Kathryn Roeder,et al. Differential Activity of Transcribed Enhancers in the Prefrontal Cortex of 537 cases with Schizophrenia and Controls , 2018, Molecular Psychiatry.
[49] Warren W. Kretzschmar,et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.
[50] A. Stark,et al. Assessing sufficiency and necessity of enhancer activities for gene expression and the mechanisms of transcription activation , 2018, Genes & development.
[51] D. Geschwind,et al. The Dynamic Landscape of Open Chromatin during Human Cortical Neurogenesis , 2018, Cell.
[52] I. Schor,et al. The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription , 2018, Genes & development.
[53] A. Gusev,et al. Probabilistic fine-mapping of transcriptome-wide association studies , 2017, bioRxiv.
[54] J. Rapoport,et al. Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains , 2017, Nature Communications.
[55] D. Weinberger,et al. Genetic insights into the neurodevelopmental origins of schizophrenia , 2017, Nature Reviews Neuroscience.
[56] Mary Goldman,et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics , 2016, Nature Communications.
[57] Wen Zhang,et al. A Bayesian Framework for Multiple Trait Colocalization from Summary Association Statistics , 2017, bioRxiv.
[58] Jakob Grove,et al. Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder , 2017, bioRxiv.
[59] P. Visscher,et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.
[60] Gerome Breen,et al. Genetic identification of brain cell types underlying schizophrenia , 2017, Nature Genetics.
[61] P. Kharchenko,et al. Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain , 2017, Nature Biotechnology.
[62] Alexander Gusev,et al. Functional Architectures of Local and Distal Regulation of Gene Expression in Multiple Human Tissues. , 2017, American journal of human genetics.
[63] Tanner Koomar,et al. cerebroViz: an R package for anatomical visualization of spatiotemporal brain data , 2016, Bioinform..
[64] J. Wysocka,et al. Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution , 2016, Cell.
[65] D. Geschwind,et al. Histone Acetylome-wide Association Study of Autism Spectrum Disorder , 2016, Cell.
[66] Alexander Gusev,et al. Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights , 2016, Nature Genetics.
[67] Benjamin A. Logsdon,et al. Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.
[68] C. Spencer,et al. A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium , 2016, bioRxiv.
[69] E. Schadt,et al. variancePartition: interpreting drivers of variation in complex gene expression studies , 2016, bioRxiv.
[70] Yoshihide Hayashizaki,et al. Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases. , 2016, Trends in genetics : TIG.
[71] H. Overkleeft,et al. Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition , 2015, Proceedings of the National Academy of Sciences.
[72] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[73] Yakir A Reshef,et al. Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.
[74] Judith B. Zaugg,et al. Genetic Control of Chromatin States in Humans Involves Local and Distal Chromosomal Interactions , 2015, Cell.
[75] J. Danesh,et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .
[76] Ji Zhang,et al. GREGOR: evaluating global enrichment of trait-associated variants in epigenomic features using a systematic, data-driven approach , 2015, Bioinform..
[77] T. Lehtimäki,et al. Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.
[78] E. Anton,et al. Developmental disruptions underlying brain abnormalities in ciliopathies , 2015, Nature Communications.
[79] Judy H. Cho,et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.
[80] Irina Voineagu,et al. Coexpression networks identify brain region–specific enhancer RNAs in the human brain , 2015, Nature Neuroscience.
[81] Joris M. Mooij,et al. MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..
[82] Ross M. Fraser,et al. Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.
[83] C. Glass,et al. The selection and function of cell type-specific enhancers , 2015, Nature Reviews Molecular Cell Biology.
[84] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.
[85] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[86] André L. Martins,et al. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers , 2014, Nature Genetics.
[87] Ross M. Fraser,et al. Defining the role of common variation in the genomic and biological architecture of adult human height , 2014, Nature Genetics.
[88] C. Spencer,et al. Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.
[89] T. Meehan,et al. An atlas of active enhancers across human cell types and tissues , 2014, Nature.
[90] Jun S. Liu,et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .
[91] Wei Wang,et al. Predicting enhancer transcription and activity from chromatin modifications , 2013, Nucleic acids research.
[92] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[93] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[94] D. Camerino,et al. Major channels involved in neuropsychiatric disorders and therapeutic perspectives , 2013, Front. Genet..
[95] G. Bejerano,et al. Enhancers: five essential questions , 2013, Nature Reviews Genetics.
[96] C. Sudlow,et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies , 2012, The Lancet Neurology.
[97] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[98] Wei Li,et al. RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..
[99] R. Durbin,et al. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses , 2012, Nature Protocols.
[100] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[101] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[102] G. Kreiman,et al. Widespread transcription at neuronal activity-regulated enhancers , 2010, Nature.
[103] M. Robinson,et al. A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.
[104] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[105] K. Anderson,et al. Mouse Kif7/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling , 2009, Proceedings of the National Academy of Sciences.
[106] Max Kuhn,et al. Building Predictive Models in R Using the caret Package , 2008 .
[107] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[108] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[109] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[110] Leo Breiman,et al. Random Forests , 2001, Machine Learning.